• Explore /
  • Poster
  • / Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM study.

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM study.

Abstract Poster

Authors

Boris A. Hadaschik

Boris A. Hadaschik

Department of Urology, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany

Boris A. Hadaschik , Nicolas Mottet , Piet Ost , Cosimo De Nunzio , Nina Tunariu , Renata Zaucha , Klaus Brasso , Ignacio Osman-Garcia , Deniz Tural , Martin Lukac , Hind Stitou , Geneviève Pissart , Michela Efficace , Stefano Fanti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04557059

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 119)

DOI

10.1200/JCO.2024.42.4_suppl.119

Abstract #

119

Poster Bd #

E12

Abstract Disclosures

Similar Posters

First Author: Jeremie Calais

First Author: Shun Zhang

Poster

2023 ASCO Genitourinary Cancers Symposium

Early biochemical outcomes following PSMA-guided approach for biochemical relapse after prostatectomy: PSICHE trial.

Early biochemical outcomes following PSMA-guided approach for biochemical relapse after prostatectomy: PSICHE trial.

First Author: Giulio Francolini

First Author: Constantinos Zamboglou